RTW Biotech Opportunities (RTW) Competitors GBX 1.12 -0.03 (-2.18%) As of 12:06 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock RTW vs. FEV, WWH, PNL, JTC, MYI, WTAN, BRW, SNN, ATT, and BHMUShould you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include Fidelity European Trust (FEV), Worldwide Healthcare (WWH), Personal Assets (PNL), JTC (JTC), Murray International (MYI), Witan Investment Trust (WTAN), Brewin Dolphin (BRW), Sanne Group (SNN), Allianz Technology Trust (ATT), and BH Macro USD (BHMU). These companies are all part of the "asset management" industry. RTW Biotech Opportunities vs. Fidelity European Trust Worldwide Healthcare Personal Assets JTC Murray International Witan Investment Trust Brewin Dolphin Sanne Group Allianz Technology Trust BH Macro USD Fidelity European Trust (LON:FEV) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations. Which has more risk and volatility, FEV or RTW? Fidelity European Trust has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, RTW Biotech Opportunities has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Which has better valuation and earnings, FEV or RTW? RTW Biotech Opportunities has higher revenue and earnings than Fidelity European Trust. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than Fidelity European Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFidelity European Trust£221.98M6.60£208.32M£50.457.07RTW Biotech Opportunities£2.12B0.18£14.09B£0.422.67 Is FEV or RTW more profitable? RTW Biotech Opportunities has a net margin of 664.38% compared to Fidelity European Trust's net margin of 93.84%. RTW Biotech Opportunities' return on equity of 25.18% beat Fidelity European Trust's return on equity.Company Net Margins Return on Equity Return on Assets Fidelity European Trust93.84% 12.65% 10.56% RTW Biotech Opportunities 664.38%25.18%-0.47% Does the MarketBeat Community believe in FEV or RTW? Fidelity European Trust received 61 more outperform votes than RTW Biotech Opportunities when rated by MarketBeat users. However, 100.00% of users gave RTW Biotech Opportunities an outperform vote while only 65.26% of users gave Fidelity European Trust an outperform vote. CompanyUnderperformOutperformFidelity European TrustOutperform Votes6265.26% Underperform Votes3334.74% RTW Biotech OpportunitiesOutperform Votes1100.00% Underperform VotesNo Votes Does the media favor FEV or RTW? In the previous week, RTW Biotech Opportunities had 2 more articles in the media than Fidelity European Trust. MarketBeat recorded 2 mentions for RTW Biotech Opportunities and 0 mentions for Fidelity European Trust. RTW Biotech Opportunities' average media sentiment score of 0.42 beat Fidelity European Trust's score of 0.00 indicating that RTW Biotech Opportunities is being referred to more favorably in the news media. Company Overall Sentiment Fidelity European Trust Neutral RTW Biotech Opportunities Neutral Do insiders & institutionals have more ownership in FEV or RTW? 69.2% of Fidelity European Trust shares are owned by institutional investors. Comparatively, 3.9% of RTW Biotech Opportunities shares are owned by institutional investors. 0.8% of Fidelity European Trust shares are owned by company insiders. Comparatively, 16.2% of RTW Biotech Opportunities shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryRTW Biotech Opportunities beats Fidelity European Trust on 8 of the 15 factors compared between the two stocks. Remove Ads Get RTW Biotech Opportunities News Delivered to You Automatically Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RTW vs. The Competition Export to ExcelMetricRTW Biotech OpportunitiesAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£376.22M£1.05B£3.95B£2.41BDividend YieldN/A4.43%4.19%4.95%P/E Ratio2.6726.1115.67127.80Price / Sales0.182,108.191,579.65257,922.55Price / Cash0.3260.8148.9727.87Price / Book0.011.043.274.33Net Income£14.09B£259.01M£1.28B£5.76B7 Day Performance-6.90%-4.96%3.74%2.05%1 Month Performance-15.79%-6.11%2.31%0.74%1 Year Performance-15.79%-1.24%6.68%92.69% RTW Biotech Opportunities Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RTWRTW Biotech OpportunitiesN/AGBX 1.12-2.2%N/A-12.9%£376.22M£2.12B2.674,971News CoverageFEVFidelity European TrustN/AGBX 399.25+0.1%N/A-4.5%£1.64B£221.98M7.91N/APositive NewsHigh Trading VolumeWWHWorldwide HealthcareN/AGBX 306.50-1.0%N/A-10.4%£1.63B£245.62M7.13N/APositive NewsHigh Trading VolumePNLPersonal AssetsN/AGBX 504.71+0.1%N/A+5.2%£1.61B£107.31M12.86N/AJTCJTC2.5279 of 5 starsGBX 955-0.3%GBX 1,250+30.9%+8.3%£1.61B£291.42M53.561,603Gap UpHigh Trading VolumeMYIMurray InternationalN/AGBX 266-0.4%N/A+2.6%£1.58B£198.15M8.85N/ADividend AnnouncementHigh Trading VolumeWTANWitan Investment TrustN/AN/AN/AN/A£1.58B£246.38M738.896BRWBrewin DolphinN/AN/AN/AN/A£1.56B£415.46M3,029.412,186SNNSanne GroupN/AN/AN/AN/A£1.50B£194.16M-204.6720,100ATTAllianz Technology TrustN/AGBX 381.37-2.2%N/A-3.0%£1.45B£511.77M2.88N/APositive NewsBHMUBH Macro USDN/AGBX 3.82flatN/A+13.9%£1.42B£2.88B32.82N/ANews CoverageHigh Trading Volume Remove Ads Related Companies and Tools Related Companies FEV Alternatives WWH Alternatives PNL Alternatives JTC Alternatives MYI Alternatives WTAN Alternatives BRW Alternatives SNN Alternatives ATT Alternatives BHMU Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:RTW) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RTW Stock Free RTW Stock Alerts